Skip to main content
. 2017 Jul-Sep;8(3):92–105. doi: 10.4103/jpp.JPP_155_16

Table 2.

Overall and individual drug wise adverse events relative risk, number needed to harm and heterogeneity results

graphic file with name JPP-8-92-g002.jpg